Dr. Narang works with founders and investors on the translation of frontier technology and advances into companies — as an Operating Partner at DCVC, as a board member and advisor to companies across the quantum stack, and as an inventor. Her focus is the stretch between a published result and a product that works, ships, and sells.
At DCVC, Dr. Narang works with founders turning breakthrough science in computing, sensing, and networking into transformative businesses. She also works with institutional investors and family offices on quantum, AI, dual-use, and defense technology.
She serves on Boards of Directors and Advisory Boards of companies across the quantum stack. Large public companies she works / has worked with include Applied Materials, Northrop Grumman, Quantinuum, and more. As a Caltech Trustee she sits on the Technology Transfer and Innovation Committee, on the question of how a research institution turns discovery into companies at scale.
Translation is not a sideline to the research; it is part of it. Dr. Narang holds multiple U.S. patents and was recognized as a Moore Inventor Fellow.
Dr. Narang is regularly quoted on quantum technology developments in the New York Times, Wall Street Journal, Fast Company, and other major outlets.
Winning the quantum race: America's blueprint for dominating the next tech revolution
New White House executive orders shift U.S. quantum policy from pure research toward building and securing a domestic quantum industry.
Core Memory, Ep. 81
Quantum vs. AI, encryption-breaking timelines, and the DCVC view.
The Next Big Quantum Computer Has Arrived
Asked about Helios’s qubit efficiency, Prineha Narang said its 2:1 physical-to-logical-qubit ratio is unique and impressive, while noting that maximizing logical qubits involves performance trade-offs.